The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Diagnostic features of atopic dermatitis

Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086

The Design and Analysis of Clinical Experiments

Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819

Severe Psoriasis – Oral Therapy with a New Retinoid

Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718

Severity Scoring of Atopic Dermatitis: The SCORAD Index

(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,304

Large sample standard errors of kappa and weighted kappa.

Fleiss, J. L., Cohen, J., & Everitt, B. S. (1969) · Psychological Bulletin · doi:10.1037/h0028106 · Cited by 1,536

Grading of the severity of atopic dermatitis.

Rajka, G., & Langeland, T. (1989) · PubMed · doi:10.2340/000155551441314 · Cited by 415

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

Sowden, J. M., Allen, B. R., Berth‐Jones, J., GRAHAM-BROWN, R. A. C., Motley, R., Finlay, A. Y., Salek, S., Marks, R., Ross, J., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

Kang, S., Lucky, A. W., Pariser, D. M., Lawrence, I., & Hanifin, J. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109812 · Cited by 329

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

Paller, A. S., Eichenfield, L. F., Leung, D. Y. M., Stewart, D., & Appell, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109813 · Cited by 323

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy

Hanifin, J. M., LING, M. R., Langley, R. G. B., Breneman, D., & Rafal, E. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109810 · Cited by 285

The positive effect of mother-performed infant massage on infantile eczema and maternal mental state: A randomized controlled trial

Lin, L., Yu, L., Zhang, S., Liu, J., & Xiong, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1068043 · Cited by 15

Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years

Siegfried, E. C., Simpson, E. L., Cork, M. J., Arkwright, P. D., Lee, L. W., Chen, Z., Prescilla, R. P., Bansal, A., Levit, N. A., & Marco, A. R. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-00960-w · Cited by 15

Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?

Ferrucci, S. M., Tavecchio, S., Nicolini, G., Angileri, L., Ceresa, A., Tordello, G. D., Berti, E., Marzano, A. V., & Buoli, M. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000511 · Cited by 15

Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis

Choo, Z.-Y., Mehlis, S. L., & Joyce, J. C. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101687 · Cited by 15

Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis

Kido‐Nakahara, M., Onozuka, D., Izuhara, K., Saeki, H., Nunomura, S., Takenaka, M., Matsumoto, M., Kataoka, Y., Fujimoto, R., Kaneko, S., et al. (2024) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2024.100317 · Cited by 15

Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis

Tanaka, A., Igawa, K., Takahashi, H., Shimizu, R., Kataoka, Y., Torisu‐Itakura, H., Morisaki, Y., Montmayeur, S., & Katoh, N. (2024) · Acta Dermato Venereologica · doi:10.2340/actadv.v104.34375 · Cited by 15

Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies

Kim, B., Silverberg, J. I., Ständer, S., Yosipovitch, G., Simpson, E. L., DiBonaventura, M., Kerkmann, U., Farooqui, S. A., Biswas, P., Valdez, H., et al. (2021) · Dermatitis · doi:10.1097/der.0000000000000770 · Cited by 15

Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients

Torisu‐Itakura, H., Anderson, P. E., Piercy, J., Pike, J., Sakamoto, A., & Kabashima, K. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2092352 · Cited by 15

Treatment with topical tacrolimus favors chronic actinic dermatitis: A clinical and immunopathological study

Ma, Y., & Zhong, L. (2010) · Journal of Dermatological Treatment · doi:10.3109/09546630903575547 · Cited by 15

Topical tacrolimus vs medium-dose ultraviolet A1 phototherapy in the treatment of atopic dermatitis - a preliminary study in relation to parameters of the epidermal barrier function and high-frequency ultrasonography.

Osmola-Mańkowska, A. J., Polańska, A., Silny, W., Żaba, R. W., Adamski, Z., & Dańczak‐Pazdrowska, A. (2014) · PubMed · Cited by 15

Comparisons of efficacy and cost-effectiveness of topical immunomodulators in the management of atopic dermatitis

Abramovits, W., Boguniewicz, M., Prendergast, M. M., Tokar, M., & Tong, K. B. (2003) · Journal of Medical Economics · doi:10.3111/200306001014 · Cited by 15

Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study

Avallone, G., Bombelli, A., Gargiulo, L., Foti, C., Trave, I., Rossi, M., Magnaterra, E., Pigliacelli, F., Malagoli, P., Giacalone, S., et al. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01550-8 · Cited by 14

RNA ‐sequencing of paired tape‐strips and skin biopsies in atopic dermatitis reveals key differences

Fritz, B. G., Halling, A., Cort, I. D., Christensen, M. O., Rønnstad, A. T. M., Olesen, C. M., Knudgaard, M. H., Zachariae, C. O. C., Heegaard, S., Thyssen, J. P., et al. (2024) · Allergy · doi:10.1111/all.16086 · Cited by 14

The beneficial effects of ethanolic extract of Sargassum serratifolium in DNCB-induced mouse model of atopic dermatitis

Kim, M.-J., Ryu, H., Jeong, H. H., Van, J. Y., Hwang, J. Y., Kim, A.-R., Seo, J., Moon, K. M., Jung, W., & Lee, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-62828-z · Cited by 14

Effect ofAlpinia katsumadaiHayata on House Dust Mite-Induced Atopic Dermatitis in NC/Nga Mice

Lim, H., Seo, C., Ha, H., Lee, H., Lee, J. K., Lee, M.-Y., & Shin, H. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/705167 · Cited by 14

Common Atopic Dermatitis Rating Scales: A Practical Approach and Brief Review

Yang, Y. B., Lynde, C. W., & Fleming, P. (2020) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475420923644 · Cited by 14

Either transepidermal water loss rates or stratum corneum hydration levels can predict quality of life in children with atopic dermatitis

Wang, S., Shen, C., Zhao, M., Jiao, L., Tian, J., Wang, Y., Ma, L., & Man, M. (2021) · Pediatric Investigation · doi:10.1002/ped4.12268 · Cited by 14

Cera Flava Alleviates Atopic Dermatitis by Activating Skin Barrier Function via Immune Regulation

Park, G., Moon, B. C., Choi, G., & Lim, H.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147531 · Cited by 14

Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review

Kaundinya, T., Rakita, U., Guraya, A., Abboud, D. M., Croce, E. A., Thyssen, J. P., Alexis, A. F., & Silverberg, J. I. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.06.033 · Cited by 14

Model-Based Meta-Analysis to Optimize Staphylococcus aureus‒Targeted Therapies for Atopic Dermatitis

Miyano, T., Irvine, A. D., & Tanaka, R. J. (2022) · JID Innovations · doi:10.1016/j.xjidi.2022.100110 · Cited by 14

Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial

Shortt, N., Martin, A., Kerse, K., Shortt, G., Vakalalabure, I., Barker, L., Singer, J., Black, B., Liu, A., Eathorne, A., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101561 · Cited by 14

Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types

Bosma, A. L., Ouwerkerk, W., Heidema, M. J., Prieto‐Merino, D., Ardern‐Jones, M. R., Beattie, P. E., Brown, S., Ingram, J. R., Irvine, A. D., Ogg, G. S., et al. (2022) · JAAD International · doi:10.1016/j.jdin.2022.09.006 · Cited by 14

Practical Training Approaches for Discordant Atopic Dermatitis Severity Datasets: Merging Methods With Soft-Label and Train-Set Pruning

Cho, S. I., Lee, D., Han, B., Lee, J. S., Hong, J. Y., Chung, J. H., Lee, D. H., & Na, J. (2022) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3218166 · Cited by 14

Breast Milk‐Derived Limosilactobacillus reuteri Prevents Atopic Dermatitis in Mice via Activating Retinol Absorption and Metabolism in Peyer's Patches

Qi, C., Tu, H., Zhao, Y., Zhou, J., Chen, J., Hu, H., Yu, R., & Sun, J. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200444 · Cited by 14

Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate–Severe Atopic Dermatitis

Thaçi, D., Singh, D., Lee, M. S., Timmis, H., Jacobs, D., Passier, P. C. C. M., Rohrer, S., Beetens, J. R., Phung, D., Sondag, E., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237244 · Cited by 14

Prevention of atopic dermatitis in high‐risk neonates via different types of moisturizer application: A randomized, blinded, parallel, three‐group, phase II trial ( PAF study)

Inuzuka, Y., Yamamoto‐Hanada, K., Kobayashi, T., Pak, K., Toyokuni, K., Ogita, H., Miyoshi, T., Ogawa, K., Sago, H., & Ohya, Y. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19375 · Cited by 14

Evodiae Fructus extract suppresses inflammatory response in HaCaT cells and improves house dust mite-induced atopic dermatitis in NC/Nga mice

Jin, S. E., Seo, C., Jeon, W., Oh, Y. J., Shin, H., Jeong, H. G., & Ha, H. (2024) · Scientific Reports · doi:10.1038/s41598-023-50257-3 · Cited by 14

Systematic literature review and evaluation of patient reported outcome measures (PROMs) for asthma and related allergic diseases

Worth, A., Hammersley, V., Nurmatov, U. B., & Sheikh, A. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00084 · Cited by 14

Evaluation of the anti-inflammatory and atopic dermatitis-mitigating effects of BSASM, a multicompound preparation

Lee, J., Jung, E., Park, B., Jung, K., Park, J., Kim, K., Kim, K. H., & Park, D. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.09.012 · Cited by 14

Evidence of regulatory myeloid dendritic cells and circulating inflammatory epidermal dendritic cells‐like modulated by Toll‐like receptors 2 and 7/8 in adults with atopic dermatitis

dos Santos, V. G., Orfali, R. L., Titz, T. D. O., Duarte, A. J. D. S., Sato, M. N., & Aoki, V. (2017) · International Journal of Dermatology · doi:10.1111/ijd.13537 · Cited by 14

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis

Kamal, M. A., Kovalenko, P., Kosloski, M. P., Srinivasan, K., Zhang, Y. C., Rajadhyaksha, M., Lai, C., Kanamaluru, V., Xu, C. R., Sun, X., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2366 · Cited by 14

Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis

Lagler, H., Bangert, C., Quint, T., Österreicher, Z. A., Nussbaumer-Pröll, A. K., Eberl, S., Weber, M., Karer, M., Sommer, M. O. A., & Zeitlinger, M. A. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04365-5 · Cited by 14

Ultra-pure soft water improves skin barrier function in children with atopic dermatitis: A randomized, double-blind, placebo-controlled, crossover pilot study

Togawa, Y., Kambe, N., Shimojo, N., Nakano, T., Sato, Y., Mochizuki, H., Tanaka, A., Matsuda, H., & Matsue, H. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.10.009 · Cited by 14

The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis

Abramovits, W., Boguniewicz, M., Paller, A. S., Whitaker-Worth, D. L., Prendergast, M. M., Tokar, M., & Tong, K. B. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523060-00003 · Cited by 14

Biodegradable core-multishell nanocarrier: Topical tacrolimus delivery for treatment of dermatitis

Radbruch, M., Pischon, H., Du, F., Haag, R., Schumacher, F., Kleuser, B., Mundhenk, L., & Gruber, A. D. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.025 · Cited by 13

Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry

Silverberg, J. I., Shi, V. Y., Alexis, A. F., Pierce, E. J., Cronin, A. M., McLean, R. R., Roberts‐Toler, C., Rueda, M. J., Atwater, A. R., & Simpson, E. L. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-00980-6 · Cited by 13

Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores

Herzum, A., Occella, C., Gariazzo, L., Pastorino, C., & Viglizzo, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216813 · Cited by 13

Circulating TSLP associates with decreased wheezing in non‐atopic preschool children: data from the URECA birth cohort

Demehri, S., Yockey, L. J., Visness, C. M., Jaffee, K. F., Turkoz, A., Wood, R. A., O’Connor, G. T., Kattan, M., Gern, J. E., Gergen, P. J., et al. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12270 · Cited by 13

Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study

Ahn, J. H., Yun, Y., Kim, M. H., Ko, S.-G., Kim, K., & Choi, I.-H. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.07.007 · Cited by 13

Young children with moderate‐to‐severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroids

Perälä, M., Ahola, M., Mikkola, T., Pelkonen, A. S., Remitz, A., & Mäkelä, M. J. (2019) · Acta Paediatrica · doi:10.1111/apa.15001 · Cited by 13

Memory Buttons in Combination with Mobile Application-Induced Objective and Subjective Effects in Patients with Atopic Dermatitis

Joergensen, K. M., Vestergaard, C., Joergensen, M. S., Eiken, A., Malmstedt-Miller, M., Schultz, A. N. Ø., Deleuran, M. S., & Zibert, J. R. (2020) · Dermatology Research and Practice · doi:10.1155/2020/8915893 · Cited by 13

Clinical examination for hyperlinear palms to determine filaggrin genotype: A diagnostic test accuracy study

Bradshaw, L. E., Haines, R., Thomas, K. S., Chalmers, J. R., Irvine, A. D., Williams, H. C., & Brown, S. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.14025 · Cited by 13

Generation and Validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire–Child (PIQ-C) to Measure the Impact of Itch on Life Quality

Paller, A. S., Lai, J., Jackson, K., Rangel, S. M., Nowinski, C. J., Silverberg, J. I., Ustsinovich, V., & Cella, D. F. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.10.015 · Cited by 13

Increased expression of Filaggrin and Claudin‐1 in the ocular surface of patients with atopic dermatitis

Callou, T. M. P., Orfali, R. L., Sotto, M. N., Pereira, N. V., Zaniboni, M. C., Aoki, V., Brito, M. P., Matsuda, M., & Santo, R. M. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17768 · Cited by 13

Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire

Zhang, J., Ragamin, A., Romeijn, G. L. E., Loman, L., Oosterhaven, J. A. F., & Schuttelaar, M. L. A. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad247 · Cited by 14

Short‐term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus

Gradman, J., & Wolthers, O. D. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00363.x · Cited by 13

Clinical Insights About Topical Treatment of Mild-to-Moderate Pediatric and Adult Atopic Dermatitis

Lynde, C. W., Bergman, J. N., Fiorillo, L., Guenther, L., Keddy-Grant, J. A., Landells, I. D. R., Marcoux, D., Ramien, M., & Rehmus, W. (2019) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475419843108 · Cited by 13

Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section I: Overview of Pediatric Atopic Dermatitis

Lara‐Corrales, I., Bergman, J. N., Landells, I. D. R., Ramien, M., & Lansang, P. (2019) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475419882049 · Cited by 13

A clinical trial for evaluation of leech application in the management of Vicarcikā (Eczema)

Shankar, K. P., Rao, S., Umar, S. N., & Gopalakrishnaiah, V. (2014) · Ancient Science of Life · doi:10.4103/0257-7941.147432 · Cited by 13

Severity assessments used for inclusion criteria and baseline severity evaluation in atopic dermatitis clinical trials: a systematic review

Chopra, R., Vakharia, P. P., Simpson, E. L., Paller, A. S., & Silverberg, J. I. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14483 · Cited by 13

Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis

Sauder, M. B., McEvoy, A., & Ramien, M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.029 · Cited by 13

Chelidonic acid ameliorates atopic dermatitis symptoms through suppression the inflammatory mediators in in vivo and in vitro

Kim, S.-J., Kim, D., Lee, S.-H., Ahn, E., Kee, J., & Hong, S. (2023) · Applied Biological Chemistry · doi:10.1186/s13765-022-00763-1 · Cited by 12

Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials

Penton, H., Jayade, S. P., Selveindran, S. M., Heisen, M., Piketty, C., Ulianov, L., Jabbar‐Lopez, Z. K., Silverberg, J. I., & Puelles, J. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-01038-3 · Cited by 12

Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1

Simpson, E. L., Blauvelt, A., Silverberg, J. I., Cork, M. J., Katoh, N., Mark, T., Schneider, S. K. R., & Wollenberg, A. (2023) · American Journal of Clinical Dermatology · doi:10.1007/s40257-023-00817-0 · Cited by 12

The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use

Jacobson, M. E., Morimoto, R. Y., Leshem, Y. A., Howells, L., Williams, H. C., Grinich, E. E., Gerbens, L. A. A., Spuls, P. I., Schmitt, J., Staley, B., et al. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20248 · Cited by 12

Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)

Simpson, E. L., Fernández‐Peñas, P., de Bruin-Weller, M. S., Lio, P., Chu, C., Ezzedine, K., Agell, H., Casillas, M., Ding, Y., Yang, F. E., et al. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02974-y · Cited by 12

Epidermal renewal during the treatment of atopic dermatitis lesions: A study coupling line‐field confocal optical coherence tomography with artificial intelligence quantifications: LC‐OCT reveals new biological markers of AD

Le Blay, H., Raynaud, E., Bouayadi, S., Rieux, E., Rolland, G., Saussine, A., Jachiet, M., Bouaziz, J., & Lynch, B. (2024) · Skin Research and Technology · doi:10.1111/srt.13891 · Cited by 12

Targeting Intracellular Pathways in Atopic Dermatitis with Small Molecule Therapeutics

Nițulescu, G., Olaru, O. T., Andrei, C., Nitulescu, G. M., & Zanfirescu, A. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080659 · Cited by 12

Ezetimibe mitigates DNCB-induced mouse model of eczematous dermatitis

Shallal, A. M., Abu-Raghif, A. R., Salman, H., Al-Zheery, W. H., & Al-Athari, A. J. H. (2025) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2025.4.7 · Cited by 12

Compound heterozygotes for filaggrin gene mutations do not always show severe atopic dermatitis

Sekiya, A., Kono, M., Tsujiuchi, H., Kobayashi, T., Nomura, T., Kitakawa, M., Suzuki, N., Yamanaka, K., Sueki, H., McLean, W. H. I., et al. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13871 · Cited by 12

Comparison of patient (POEM), observer (EASI, SASSAD, TIS) and corneometry measures of emollient effectiveness in children with eczema: findings from the COMET feasibility trial

Ridd, M. J., Gaunt, D., Guy, R. H., Redmond, N. M., Garfield, K., Hollinghurst, S. P., Ball, N., Shaw, L., Purdy, S., & Metcalfe, C. D. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16475 · Cited by 12

Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores

Wollenberg, A., Simon, D., Kulthanan, K., Figueras‐Nart, I., Misery, L., Tangsirisap, N., Spina, L., Lu, N., Grond, S., & Eyerich, K. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19669 · Cited by 12

Phenotyping acute and chronic atopic dermatitis-like lesions in Stat6VT mice identifies a role for IL-33 in disease pathogenesis

DaSilva‐Arnold, S. C., Thyagarajan‐Sahu, A., Seymour, L. J., Yi, Q., Bradish, J. R., Al‐Hassani, M., Zhou, H., Perdue, N. J., Nemeth, V., Krbanjevic, A., et al. (2018) · Archives of Dermatological Research · doi:10.1007/s00403-018-1807-y · Cited by 13

Psychosomatic factors of atopic dermatitis exacerbation

Maksimović, N., Zarić, M., Bjelica, S., Marinković, J., & Janković, S. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14076 · Cited by 12

Correlation of Blood FoxP3+ Regulatory T Cells and Disease Activity of Atopic Dermatitis

Li, Y., Xu, W., Yao, J., Cheng, H., Sun, X., & Li, L. (2019) · Journal of Immunology Research · doi:10.1155/2019/1820182 · Cited by 12

Prevalence and clinical characteristics of adult-onset atopic dermatitis with positive skin prick testing to mites.

Kulthanan, K., Chularojanamontri, L., Manapajon, A., & Nuchkull, P. (2011) · PubMed · Cited by 12

Metabolomics reveals microbial‐derived metabolites associated with immunoglobulin E responses in filaggrin ‐related atopic dermatitis

Chiu, C., Lin, G., Wang, C., Chung, W., & Chung, W. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13570 · Cited by 12

Topical 0.03% tacrolimus ointment, 0.05% clobetasone butyrate cream alone and their combination in older children with atopic dermatitis - an open randomized comparative study

Sikder, M. A. U., Mamun, S. A., Khan, R. M., Chowdhury, A. H., Khan, H. M., & Hoque, M. M. (2016) · Journal of Pakistan Association of Dermatologists · doi:10.66344/jpad.v15i4.663 · Cited by 12

The Turkish guideline for the diagnosis and management of atopic dermatitis-2018

Ertam, İ., Su, Ö., Alper, S., Sarıcaoğlu, H., Karadağ, A. S., Demirsoy, E. O., & Borlu, M. (2018) · TURKDERM · doi:10.4274/turkderm.87143 · Cited by 12

Treatment patterns in UK adult patients with atopic dermatitis treated with systemic immunosuppressants: data from The Health Improvement Network (THIN)

Eckert, L., Amand, C., Gadkari, A. S., Rout, R., Hudson, R. D. A., & Ardern‐Jones, M. R. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1639604 · Cited by 12

A Sensorised Glove to Detect Scratching for Patients with Atopic Dermatitis

Au, C.-Y., Leow, S. Y., Yi, C., Ang, D., Yeo, J. C., Koh, M. J. A., & Bhagat, A. A. S. (2023) · Sensors · doi:10.3390/s23249782 · Cited by 12

A quantitative systems pharmacology workflow toward optimal design and biomarker stratification of atopic dermatitis clinical trials

Go, N., Arsène, S., Faddeenkov, I., Galland, T., Shiny Martis, B., Lefaudeux, D., Wang, Y., Éthève, L., Jacob, E., Monteiro, C., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.12.031 · Cited by 12

Investigating Distinct Skin Microbial Communities and Skin Metabolome Profiles in Atopic Dermatitis

Kim, S., Cho, M., Jung, E. S., Sim, I., & Woo, Y. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105211 · Cited by 11

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial)

Fieten, K. B., Zijlstra, W. T., van Os‐Medendorp, H., Meijer, Y., Venema, M. U., Rijssenbeek-Nouwens, L., l’Hoir, M. P., Bruijnzeel-Koomen, C. A. F. M., & Pasmans, S. G. M. A. (2014) · Trials · doi:10.1186/1745-6215-15-94 · Cited by 11

The effect of Tegaderm™ versus EyeGard® on eyelid erythema during general anesthesia: a randomized-controlled trial

Drzymalski, D. M., Ward, K. R., Hernandez, J. M., Hoot, J. W., Au, S.-C., Yang, F. C., & Azocar, R. J. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01588-6 · Cited by 11

Development and Initial Psychometric Properties of Two Itch-Related Measures: Scratch Intensity and Impact, Sleep-Related Itch and Scratch

Heckman, C. J., Riley, M. C., Valdés‐Rodríguez, R., & Yosipovitch, G. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.03.961 · Cited by 11

Immunotherapy in Atopic Dermatitis

Li, W., & Man, X. (2022) · Immunotherapy · doi:10.2217/imt-2022-0054 · Cited by 11

Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis

Reich, K., Lio, P., Bissonnette, R., Alexis, A. F., Lebwohl, M., Pink, A., Kabashima, K., Boguniewicz, M., Nowicki, R. J., Valdez, H., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.08.042 · Cited by 11

Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis

Ferrucci, S. M., Casazza, G., Zussino, M., Tavecchio, S., Marzano, A. V., & Tedeschi, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206575 · Cited by 12

Efficacy and safety of lebrikizumab combined with topical corticosteroids in Japanese patients with moderate-to-severe atopic dermatitis: a phase 3, double-blind, placebo-controlled, randomized clinical trial (ADhere-J)

Katoh, N., Tanaka, A., Takahashi, H., Shimizu, R., Kataoka, Y., Torisu‐Itakura, H., Morisaki, Y., & Igawa, K. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2436982 · Cited by 11

Effect of Chrysanthemi borealis flos on atopic dermatitis induced by 1-chloro 2,4-dinitrobenzene in NC/Nga mouse

Yang, G., Lee, K., An, D.-G., Lee, M., Ham, I., & Choi, H. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.613401 · Cited by 11

Treatment of Atopic Dermatitis Using a Full-Body Blue Light Device (AD-Blue): Protocol of a Randomized Controlled Trial

Kromer, C., Nühnen, V. P., Pfützner, W., Pfeiffer, S., Laubach, H., Boehncke, W., Liebmann, J., Born, M., Schön, M. P., & Buhl, T. (2019) · JMIR Research Protocols · doi:10.2196/11911 · Cited by 11

Different strategies for using topical corticosteroids in people with eczema

Chalmers, J. R., Axon, E., Harvey, J., Santer, M., Ridd, M. J., Lawton, S., Langan, S., Roberts, A., Ahmed, A. I., Müller, I., et al. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013356 · Cited by 11

Hybrid Computational Intelligence Technique: Eczema Detection

Arora, Y. K., Tandon, A., & Nijhawan, R. (2019) · IEEE Region 10 Conference (TENCON) · doi:10.1109/tencon.2019.8929578 · Cited by 11

Longitudinal course and phenotypes of health‐related quality of life in adults with atopic dermatitis

Schwartzman, G. H., Lei, D. K., Ahmed, A., Chavda, R., Gabriel, S., & Silverberg, J. I. (2021) · Clinical and Experimental Dermatology · doi:10.1111/ced.14948 · Cited by 11

Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis for Whom Narrow-Band UVB (NB-UVB) and Medium-Dose UVA1 Phototherapies Are Still Valuable Treatment Options at the Age of Biologics

Rossi, M., Damiani, C., Arisi, M., Tomasi, C., Tonon, F., Venturini, M., & Calzavara‐Pinton, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093303 · Cited by 11

Tissue inhibitors of matrix metalloproteinase‐1 levels are increased in serum of patients with allergic contact dermatitis

Reduta, T., Laudańska, H., & Laudański, P. (2007) · Contact Dermatitis · doi:10.1111/j.1600-0536.2007.01167.x · Cited by 11

Identification of Staphylococcal Protein A in Infected Atopic Dermatitis Lesions

Yao, Y., Kozman, A., Al‐Hassani, M., Saha, C., Yi, Q., Yao, W., Mousdicas, N., Kaplan, M. H., & Travers, J. B. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.154 · Cited by 11

Use of Emollients in Atopic Dermatitis: A Questionnaire Survey Study

Lee, J. H., Jung, K. E., Lee, Y. B., Kim, J. E., Kim, H. S., Lee, K. H., Park, Y. M., Cho, S. H., & Lee, J. Y. (2014) · Annals of Dermatology · doi:10.5021/ad.2014.26.4.528 · Cited by 11

The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis

Baek, J. H., Park, C. W., Choi, K. M., Yang, Y. S., Lee, S. Y., Koh, J. S., Chung, B. Y., Kim, H. O., & Park, G. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12711 · Cited by 11

The Effects of Latent Attitudinal Variables and Sociodemographic Differences on Travel Behavior in Two Small, Underdeveloped Cities in China

Cheng, G., Zhao, S., & Li, L. (2019) · Sustainability · doi:10.3390/su11051306 · Cited by 11

Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab

Mizuno, M., Horiguchi, G., Teramukai, S., Ichiyama, S., Ito, M., Hoashi, T., Kanda, N., & Saeki, H. (2021) · Australasian Journal of Dermatology · doi:10.1111/ajd.13719 · Cited by 11

The Usefulness of Line-Field Confocal Optical Coherence Tomography in Monitoring Epidermal Changes in Atopic Dermatitis in Response to Treatment: A Pilot Study

Dryżałowska, Z., Blicharz, L., Michalczyk, A., Kościan, J., Maj, M., Czuwara, J., & Rudnicka, L. (2024) · Diagnostics · doi:10.3390/diagnostics14161724 · Cited by 10

Efficacy and safety of systemic targeted therapies for atopic dermatitis in children: A systematic review and meta-analysis

Kawamoto, N., Murai, H., Nogami, K., Yamamoto, T., Kikkawa, T., Yasutomi, M., Yamamoto‐Hanada, K., Futamura, M., & Ohya, Y. (2025) · Allergology International · doi:10.1016/j.alit.2024.11.007 · Cited by 10

Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis

Murase, J. E., Eyerich, K., Chovatiya, R., Hong, H., Bangert, C., Strowd, L. C., Deleuran, M. S., Atwater, A. R., Rueda, M. J., Elmaraghy, H., et al. (2025) · Journal of Dermatological Treatment · doi:10.1080/09546634.2025.2492188 · Cited by 10

Seromarkers in childhood atopic dermatitis

Hon, K. E., & Leung, T. F. (2010) · Expert Review of Dermatology · doi:10.1586/edm.10.21 · Cited by 10

ASSOCIAÇÃO MÉDICA BRASILEIRA

Foco, E. (2016) · Cited by 10

Digital Health Sensing for Personalized Dermatology

Spinazze, P., Bottle, A., & Car, J. (2019) · Sensors · doi:10.3390/s19153426 · Cited by 10

Self‐reported stigmatisation among patients with atopic dermatitis (AD) or chronic spontaneous urticaria (CSU): A cross‐sectional study

Wiis, M. A. K., Heilskov, S., Sørensen, J. A., Bang, K., Egekvist, H., Deleuran, M. S., Thyssen, J. P., Thomsen, S. F., & Vestergaard, C. (2022) · JEADV Clinical Practice · doi:10.1002/jvc2.46 · Cited by 10

Therapeutic effects and mechanisms of Ku-Gan formula on atopic dermatitis: A pilot clinical study and modular pharmacology analysis with animal validation

Ma, X., Kuai, L., Song, J., Luo, Y., Ru, Y., Wang, M., Gao, C., Jiang, W., Liu, Y., Bai, Y., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116194 · Cited by 10

Interobserver Agreement of the Eczema Area and Severity Index for Atopic Dermatitis Severity Assessment: A Real-World Evidence Study

Villa-González, J. M., Gonzalez-Hermosa, M. R., Alzaga, J. U., Blasco, R. P., Ibarrola, P. A., Atxutegi‐Ayesta, X., García, A. G., Aguirre, I. I., del Tánago, B. U. G., Ares, M. P., et al. (2025) · Dermatitis · doi:10.1089/derm.2025.0054 · Cited by 2

What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study

Leshem, Y. A., Hajar, T., Hanifin, J. M., & Simpson, E. L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13662 · Cited by 295

How Adequately is the Severity of Atopic Dermatitis Assessed by Resident Physicians Training in Dermatology? Evaluation of the Intrarater and Interrater Reliability of Clinical Scoring Systems (EASI, oSCORAD, IGA, TIS Score, SASSAD)

Waligóra-Dziwak, K., Kubiak, K. B., Dańczak‐Pazdrowska, A., & Jenerowicz, D. (2026) · Acta Dermato Venereologica · doi:10.2340/actadv.v106.43964 · Cited by 1

Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA

Bożek, A., & Reich, A. (2017) · Dermatology · doi:10.1159/000472711 · Cited by 74

The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis

Baek, J. H., Park, C. W., Choi, K. M., Yang, Y. S., Lee, S. Y., Koh, J. S., Chung, B. Y., Kim, H. O., & Park, G. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12711 · Cited by 11